{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:12:49Z","timestamp":1793524369366,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA046345"],"award-info":[{"award-number":["P30 DA046345"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neubiorev.2024.105713","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T21:55:32Z","timestamp":1715378132000},"page":"105713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A review of the kappa opioid receptor system in opioid use"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-5188","authenticated-orcid":false,"given":"Salih","family":"Cayir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Zhornitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Barzegary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Sotomayor-Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonder","family":"Sarfo-Ansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Funaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.neubiorev.2024.105713_bib1","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1523\/JNEUROSCI.0653-18.2018","article-title":"Estrogen regulation of GRK2 inactivates kappa opioid receptor signaling mediating analgesia, but not aversion","volume":"38","author":"Abraham","year":"2018","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.neubiorev.2024.105713_bib2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41386-021-01168-2","article-title":"Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition","volume":"46","author":"Abraham","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0014-2999(82)90299-0","article-title":"Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys","volume":"83","author":"Aceto","year":"1982","journal-title":"Eur. J. Pharm."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105713_bib4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0024-3205(91)90039-E","article-title":"Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs","volume":"48","author":"Adams","year":"1991","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib5","doi-asserted-by":"crossref","DOI":"10.5812\/jjcmb.121808","article-title":"Region specificity in endogenous opioid peptides and Mu-opioid receptor gene expression in rat brain areas involved in addiction after frequent morphine treatment [Research Article]","volume":"12","author":"Ahmadi","year":"2021","journal-title":"Jentashapir J. Cell Mol. Biol."},{"key":"10.1016\/j.neubiorev.2024.105713_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/164_2019_268","article-title":"The rise and fall of kappa-opioid receptors in drug abuse research","volume":"258","author":"Banks","year":"2020","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.neubiorev.2024.105713_bib7","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fnins.2019.01392","article-title":"Escalated oxycodone self-administration and punishment: differential expression of opioid receptors and immediate early genes in the rat dorsal striatum and prefrontal cortex","volume":"13","author":"Blackwood","year":"2019","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105713_bib8","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s12035-018-1318-z","article-title":"Molecular adaptations in the rat dorsal striatum and hippocampus following abstinence-induced incubation of drug seeking after escalated oxycodone self-administration","volume":"56","author":"Blackwood","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib9","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/ejn.13955","article-title":"Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking","volume":"50","author":"Bossert","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105713_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41386-023-01561-z","article-title":"Kappa opioid receptors as modulators of novelty processing","volume":"48","author":"Braden","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"2-3","key":"10.1016\/j.neubiorev.2024.105713_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-2999(93)90196-O","article-title":"The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs","volume":"241","author":"Brent","year":"1993","journal-title":"Eur. J. Pharm."},{"issue":"18","key":"10.1016\/j.neubiorev.2024.105713_bib12","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.15165","article-title":"Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour","volume":"177","author":"Brice-Tutt","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.neubiorev.2024.105713_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173405","article-title":"An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference","volume":"217","author":"Brice-Tutt","year":"2022","journal-title":"Pharm. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep30797","article-title":"Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design","volume":"6","author":"Broad","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008528","article-title":"CRF1-R activation of the dynorphin\/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior","volume":"4","author":"Bruchas","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainresrev.2009.09.008","article-title":"kappa-Opioid receptor signaling and brain reward function","volume":"62","author":"Bruijnzeel","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.npp.1301192","article-title":"Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats","volume":"32","author":"Bruijnzeel","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2024.105713_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.708283","article-title":"A systematic review of opioid use disorder and related biomarkers","volume":"12","author":"Bryant","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2024.105713_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2023.07.031","article-title":"Neuroimmune mechanisms of opioid use disorder and recovery: translatability to human studies, and future research directions","volume":"528","author":"Butelman","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2024.105713_bib21","series-title":"The Kappa Opioid Receptor","first-page":"3","article-title":"Fundamentals of the Dynorphins\/Kappa Opioid Receptor System: From Distribution to Signaling and Function","author":"Cahill","year":"2022"},{"issue":"2-3","key":"10.1016\/j.neubiorev.2024.105713_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-2999(98)00874-7","article-title":"A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides","volume":"365","author":"Cappendijk","year":"1999","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-010-1832-9","article-title":"Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats","volume":"210","author":"Carr","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"1-3","key":"10.1016\/j.neubiorev.2024.105713_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2005.09.013","article-title":"Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model","volume":"524","author":"Carroll","year":"2005","journal-title":"Eur. J. Pharm."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib25","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1523\/JNEUROSCI.4458-13.2014","article-title":"Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness \"liking\" and \"wanting","volume":"34","author":"Castro","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2024.105713_bib26","unstructured":"CDC. (2023). \u3008https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates\u3009."},{"key":"10.1016\/j.neubiorev.2024.105713_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00466","article-title":"Sex differences in Kappa opioid receptor function and their potential impact on addiction [Review]","volume":"9","author":"Chartoff","year":"2015","journal-title":"Front. Neurosci."},{"issue":"13","key":"10.1016\/j.neubiorev.2024.105713_bib28","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/npp.2013.171","article-title":"Kappa opioid receptors on dopaminergic neurons are necessary for Kappa-mediated place aversion","volume":"38","author":"Chefer","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41401-022-00987-3","article-title":"Upregulation of dynorphin\/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion","volume":"44","author":"Chen","year":"2023","journal-title":"Acta Pharm. Sin."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3565(24)29518-5","article-title":"Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine","volume":"297","author":"Cichewicz","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(00)01593-7","article-title":"Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat","volume":"295","author":"Cui","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2024.105713_bib32","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch. Int. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0361-9230(02)00760-8","article-title":"Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain","volume":"58","author":"Fan","year":"2002","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib34","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0306-4522(03)00299-9","article-title":"Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol","volume":"121","author":"Fan","year":"2003","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib35","first-page":"18","article-title":"Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression","volume":"32","author":"Fava","year":"2020","journal-title":"Ann. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-3565(24)37040-5","article-title":"Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats","volume":"283","author":"Feng","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"issue":"14","key":"10.1016\/j.neubiorev.2024.105713_bib37","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00213-014-3436-2","article-title":"Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys","volume":"231","author":"Freeman","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(89)90132-5","article-title":"Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats","volume":"170","author":"Fukagawa","year":"1989","journal-title":"Eur. J. Pharm."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib39","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0028-3908(93)90026-Y","article-title":"Blockade of morphine reward through the activation of kappa-opioid receptors in mice","volume":"32","author":"Funada","year":"1993","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib40","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jnr.23277","article-title":"Early modulation by the dopamine D4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen","volume":"91","author":"Gago","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2024.105713_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000324065","article-title":"Addiction and brain reward and antireward pathways","volume":"30","author":"Gardner","year":"2011","journal-title":"Adv. Psychosom. Med."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","article-title":"Kappa opioid inhibition of morphine and cocaine self-administration in rats","volume":"681","author":"Glick","year":"1995","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib43","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.76.12.6666","article-title":"Dynorphin-(1-13), an extraordinarily potent opioid peptide","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(88)90429-3","article-title":"Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration","volume":"145","author":"Green","year":"1988","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib45","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-3565(24)36704-7","article-title":"Human pharmacology of the opioid neuropeptide dynorphin A(1-13)","volume":"281","author":"Greenwald","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.03.051","article-title":"Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5","volume":"169","author":"Gregus","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2024.105713_bib47","article-title":"The effects of heroin on the expression of \u039c-opioid receptors, \u039a-opioid recep- tors and creb pathway-related molecules in the ventral tegmental area and the nucleus accumbens of rats","volume":"1","author":"Hong","year":"2019","journal-title":"Acta Med. Mediterr."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3565(25)09537-0","article-title":"Dynorphin A modulates acute and chronic opioid effects","volume":"273","author":"Hooke","year":"1995","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib49","first-page":"15","article-title":"U-50488 decreases the rewarding effect and mesolimbic dopamine neuron activity induced by morphine in rats","volume":"27","author":"Huang","year":"2007","journal-title":"J. Med. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45584-4","article-title":"Effects of the novel selective \u03ba-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors","volume":"13","author":"Ide","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0026-895X(25)14957-2","article-title":"Site-directed alkylation of multiple opioid receptors. I. Binding selectivity","volume":"25","author":"James","year":"1984","journal-title":"Mol. Pharm."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2024.105713_bib52","first-page":"347","article-title":"Methadone maintenance treatment (MMT): a review of historical and clinical issues","volume":"67","author":"Joseph","year":"2000","journal-title":"Mt Sinai J. Med."},{"key":"10.1016\/j.neubiorev.2024.105713_bib53","article-title":"Youth fatal drug overdose and suicide: trends in Connecticut, 2019-2021","author":"Kaminer","year":"2023","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neubiorev.2024.105713_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146742","article-title":"Dynorphin and its role in alcohol use disorder","volume":"1735","author":"Karkhanis","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2024.105713_bib55","series-title":"Handbook of biologically active peptides","author":"Kastin","year":"2013"},{"key":"10.1016\/j.neubiorev.2024.105713_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbr.2015.01.008","article-title":"The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats","volume":"283","author":"Kelsey","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2024.105713_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114785","article-title":"A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse","volume":"243","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.neubiorev.2024.105713_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0024-3205(83)90564-7","article-title":"Self-administration of dynorphin-[1\u201313] and D-ala2-dynorphin-[1\u201311] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats","volume":"33","author":"Khazan","year":"1983","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(89)90231-8","article-title":"Effects of pentazocine and other opioids on the potassium-evoked release of [3H]noradrenaline from guinea pig cortical slices","volume":"164","author":"Kinouchi","year":"1989","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainresbull.2006.05.005","article-title":"Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime","volume":"70","author":"Kir\u00e1ly","year":"2006","journal-title":"Brain Res. Bull."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2024.105713_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2008.02.035","article-title":"Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors","volume":"586","author":"Klein","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.neubiorev.2024.105713_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fpsyt.2013.00072","article-title":"Addiction is a reward deficit and stress surfeit disorder","volume":"4","author":"Koob","year":"2013","journal-title":"Front Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105713_bib63","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn1105-1442","article-title":"Plasticity of reward neurocircuitry and the 'dark side' of drug addiction","volume":"8","author":"Koob","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2024.105713_bib64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-pharmtox-010715-103143","article-title":"Existing and future drugs for the treatment of the dark side of addiction","volume":"56","author":"Koob","year":"2016","journal-title":"Annu. Rev. Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105713_bib66","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41591-020-0806-7","article-title":"A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating \u03ba-opioid antagonism as a treatment for anhedonia","volume":"26","author":"Krystal","year":"2020","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(96)00961-2","article-title":"Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice","volume":"321","author":"Kuzmin","year":"1997","journal-title":"Eur. J. Pharm."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib68","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nn1804","article-title":"Dynorphin A activates bradykinin receptors to maintain neuropathic pain","volume":"9","author":"Lai","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2024.105713_bib69","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","article-title":"The kappa opioid receptor: from addiction to depression, and back","volume":"5","author":"Lalanne","year":"2014","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib70","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.pain.2010.09.018","article-title":"Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia","volume":"151","author":"Lawson","year":"2010","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105713_bib71","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1046\/j.1460-9568.2003.02678.x","article-title":"Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system","volume":"17","author":"Le Guen","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"10118","key":"10.1016\/j.neubiorev.2024.105713_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2024.105713_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2010.02.070","article-title":"The kappa-opioid receptor is upregulated in the spinal cord and locus ceruleus but downregulated in the dorsal root ganglia of morphine tolerant rats","volume":"1326","author":"Li","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2024.105713_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1744-8069-10-59","article-title":"Epigenetic regulation of spinal cord gene expression controls opioid-induced hyperalgesia","volume":"10","author":"Liang","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neubiorev.2024.105713_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1113\/jphysiol.1988.sp017261","article-title":"Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat","volume":"403","author":"Lightman","year":"1988","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib76","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0028-3908(92)90051-P","article-title":"Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists","volume":"31","author":"Maldonado","year":"1992","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105713_bib77","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2024.105713_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100325","article-title":"\u03ba-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats","volume":"14","author":"Marchette","year":"2021","journal-title":"Neurobiol. Stress"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105713_bib79","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41386-019-0398-4","article-title":"Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study","volume":"44","author":"Martinez","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neubiorev.2024.105713_bib80","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41386-019-0379-7","article-title":"Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers","volume":"44","author":"Matuskey","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"25","key":"10.1016\/j.neubiorev.2024.105713_bib81","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1523\/JNEUROSCI.0062-05.2005","article-title":"Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area","volume":"25","author":"McClung","year":"2005","journal-title":"J. Neurosci."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-3806(00)00102-4","article-title":"The role of opioid receptors in morphine withdrawal in the infant rat. Brain Res","volume":"124","author":"McPhie","year":"2000","journal-title":"Dev. Brain Res"},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105713_bib83","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2967\/jnumed.119.227694","article-title":"Kinetic Modeling and Test-Retest Reproducibility of (11)C-EKAP and (11)C-FEKAP, Novel Agonist Radiotracers for PET Imaging of the \u03ba-Opioid Receptor in Humans","volume":"61","author":"Naganawa","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib84","first-page":"15","article-title":"Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice","volume":"62","author":"Narita","year":"1993","journal-title":"Jpn. J. Pharm."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105713_bib85","first-page":"379","article-title":"Changes in the levels of several endogenous opioid peptides in dog cerebrospinal fluid following morphine administration","volume":"28","author":"Natsuki","year":"1993","journal-title":"Arukoru Kenkyuto Yakubutsu Ison"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib86","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/npp.2008.127","article-title":"Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys","volume":"34","author":"Negus","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib87","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0022-3565(25)38246-7","article-title":"Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats","volume":"265","author":"Negus","year":"1993","journal-title":"J. Pharm. Exp. Ther."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105713_bib88","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1037\/a0013088","article-title":"Micro\/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability","volume":"16","author":"Negus","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2024.105713_bib89","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0028-3908(91)90168-B","article-title":"Levels of dynorphin peptides, substance P and CGRP in the spinal cord after subchronic administration of morphine in the rat","volume":"30","author":"Nylander","year":"1991","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib90","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02245939","article-title":"The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats","volume":"118","author":"Nylander","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00279-Y","article-title":"Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal","volume":"683","author":"Nylander","year":"1995","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105713_bib92","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0006-3223(88)90139-4","article-title":"Endogenous opioids in cerebrospinal fluid of opioid-dependent humans","volume":"24","author":"O'Brien","year":"1988","journal-title":"Biol. Psychiatry"},{"issue":"4765","key":"10.1016\/j.neubiorev.2024.105713_bib93","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2024.105713_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108341","article-title":"Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis","volume":"181","author":"Pirino","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib95","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jjp.37.307","article-title":"An analysis of precipitated withdrawal in rats acutely dependent on morphine","volume":"37","author":"Ramabadran","year":"1985","journal-title":"Jpn. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(97)00084-X","article-title":"Effect of chronic treatment with morphine, midazolam and both together on dynorphin(1-13) levels in the rat","volume":"754","author":"Rattan","year":"1997","journal-title":"Brain Res."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib97","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(92)90896-H","article-title":"The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat","volume":"584","author":"Rattan","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2024.105713_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916641950","article-title":"Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure","volume":"12","author":"Sahbaie","year":"2016","journal-title":"Mol. Pain"},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105713_bib99","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.150.5.695","article-title":"Should protracted withdrawal from drugs be included in DSM-IV?","volume":"150","author":"Satel","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"49","key":"10.1016\/j.neubiorev.2024.105713_bib100","doi-asserted-by":"crossref","first-page":"19384","DOI":"10.1523\/JNEUROSCI.1979-13.2013","article-title":"Long-term antagonism of \u03ba opioid receptors prevents escalation of and increased motivation for heroin intake","volume":"33","author":"Schlosburg","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib101","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2011.07.013","article-title":"Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL\/6J and 129P3\/J mice: strain and heroin effects","volume":"100","author":"Schlussman","year":"2011","journal-title":"Pharm. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2024.105713_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107638","article-title":"Evaluation of dynorphin and kappa-opioid receptor level in the human blood lymphocytes and plasma: possible role as a biomarker in severe opioid use disorder","volume":"205","author":"Shahkarami","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(97)01614-2","article-title":"Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593","volume":"345","author":"Shippenberg","year":"1998","journal-title":"Eur. J. Pharm."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130000475","article-title":"Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat","volume":"151","author":"Shippenberg","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib106","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0091-3057(02)00993-0","article-title":"Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis","volume":"74","author":"Sinchaisuk","year":"2002","journal-title":"Pharm. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib108","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/jpet.108.150011","article-title":"The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors","volume":"330","author":"Smith","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2024.105713_bib109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2008.12.002","article-title":"Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration","volume":"1255","author":"Solecki","year":"2009","journal-title":"Brain Res."},{"issue":"47","key":"10.1016\/j.neubiorev.2024.105713_bib110","doi-asserted-by":"crossref","first-page":"82632","DOI":"10.18632\/oncotarget.19671","article-title":"Expression of protein kinase A and the kappa opioid receptor in selected brain regions and conditioned place aversion in morphine-dependent rats","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib111","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0306-4522(94)90524-X","article-title":"Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine","volume":"63","author":"Spanagel","year":"1994","journal-title":"Neuroscience"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02244761","article-title":"Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release","volume":"115","author":"Spanagel","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib113","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s002130050626","article-title":"Effects of dynorphin A(1-13) on opiate withdrawal in humans","volume":"137","author":"Specker","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(92)90237-X","article-title":"Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine","volume":"213","author":"Suzuki","year":"1992","journal-title":"Eur. J. Pharm."},{"issue":"2-3","key":"10.1016\/j.neubiorev.2024.105713_bib115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(92)90705-9","article-title":"Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice","volume":"221","author":"Takemori","year":"1992","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib116","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(94)90553-3","article-title":"U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs","volume":"256","author":"Tao","year":"1994","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib117","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/PL00004944","article-title":"The role of vasopressin on the effect of U-50,488 to block the development of morphine tolerance and physical dependence","volume":"355","author":"Tao","year":"1997","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib118","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.pbb.2008.04.008","article-title":"Behavioral effects of acute stimulation of kappa-opioid receptors during lactation","volume":"90","author":"Teodorov","year":"2008","journal-title":"Pharm. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib119","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(96)00363-6","article-title":"Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration","volume":"76","author":"Tjon","year":"1997","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib120","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00213-020-05749-9","article-title":"Effects of kappa opioid receptor agonists on fentanyl vs. food choice in male and female rats: contingent vs. non-contingent administration","volume":"238","author":"Townsend","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"17","key":"10.1016\/j.neubiorev.2024.105713_bib121","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00213-017-4652-3","article-title":"Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats","volume":"234","author":"Townsend","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neubiorev.2024.105713_bib122","first-page":"550","article-title":"Changes in prodynorphin peptide content following treatment with morphine or amphetamine: possible role in mechanisms of action of drug of abuse","volume":"95","author":"Trujillo","year":"1989","journal-title":"NIDA Res. Monogr."},{"issue":"25","key":"10.1016\/j.neubiorev.2024.105713_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(00)80011-9","article-title":"A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice","volume":"66","author":"Tsuji","year":"2000","journal-title":"Life Sci."},{"issue":"15","key":"10.1016\/j.neubiorev.2024.105713_bib124","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0024-3205(01)00957-2","article-title":"The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice","volume":"68","author":"Tsuji","year":"2001","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(25)32800-4","article-title":"Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia","volume":"219","author":"Tulunay","year":"1981","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2024.105713_bib126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2014.12.012","article-title":"ASICs and neuropeptides","volume":"94","author":"Vick","year":"2015","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib127","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000220763","article-title":"Effects of neonatal stress and morphine on kappa opioid receptor signaling","volume":"96","author":"Vien","year":"2009","journal-title":"Neonatology"},{"issue":"10118","key":"10.1016\/j.neubiorev.2024.105713_bib128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(17)32893-3","article-title":"Medications for opioid use disorder: bridging the gap in care","volume":"391","author":"Volkow","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The Role of Science in Addressing the Opioid Crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4577","key":"10.1016\/j.neubiorev.2024.105713_bib130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1126\/science.6128791","article-title":"Nonopiate effects of dynorphin and des-Tyr-dynorphin","volume":"218","author":"Walker","year":"1982","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neubiorev.2024.105713_bib131","first-page":"560","article-title":"Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats","volume":"19","author":"Wan","year":"1998","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2024.105713_bib132","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0169-328X(99)00021-2","article-title":"Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain","volume":"66","author":"Wang","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","article-title":"The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse","volume":"210","author":"Wee","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.neubiorev.2024.105713_bib134","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.euroneuro.2007.04.001","article-title":"Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats","volume":"17","author":"Wei","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(87)90506-1","article-title":"Differential effects of heroin on opioid levels in the rat brain","volume":"139","author":"Weissman","year":"1987","journal-title":"Eur. J. Pharm."},{"issue":"3-4","key":"10.1016\/j.neubiorev.2024.105713_bib136","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(82)90509-X","article-title":"Suppression of withdrawal symptoms by dynorphin in heroin addicts","volume":"82","author":"Wen","year":"1982","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib137","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(84)90217-6","article-title":"Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal","volume":"100","author":"Wen","year":"1984","journal-title":"Eur. J. Pharm."},{"issue":"7, Part 2","key":"10.1016\/j.neubiorev.2024.105713_bib138","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0028-3908(87)90077-3","article-title":"Opioid receptor regulation of the release of norepinephrine in brain","volume":"26","author":"Werling","year":"1987","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2024.105713_bib139","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(25)13264-3","article-title":"Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex","volume":"247","author":"Werling","year":"1988","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.neubiorev.2024.105713_bib140","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0091-3057(98)00074-4","article-title":"Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine","volume":"60","author":"Wongchanapai","year":"1998","journal-title":"Pharm. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib141","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3565(24)37186-1","article-title":"Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study","volume":"284","author":"Xi","year":"1998","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2024.105713_bib142","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1734-1140(12)70786-7","article-title":"Differential effects of acute and repeated morphine treatment on \u03ba-opioid receptor mRNA levels in mesocorticolimbic system","volume":"64","author":"Yu","year":"2012","journal-title":"Pharm. Rep."},{"issue":"1","key":"10.1016\/j.neubiorev.2024.105713_bib143","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10799893.2013.856919","article-title":"Effects of acute and repeated morphine treatment on \u03ba-opioid receptor protein levels in mesocorticolimbic system","volume":"34","author":"Yu","year":"2014","journal-title":"J. Recept Signal Transduct. Res."},{"issue":"7","key":"10.1016\/j.neubiorev.2024.105713_bib144","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0028-3908(93)90084-G","article-title":"Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens","volume":"32","author":"Yukhananov","year":"1993","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neubiorev.2024.105713_bib145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/FBP.0000000000000581","article-title":"The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone's conditioned rewarding effects in male rats","volume":"31","author":"Zamarripa","year":"2020","journal-title":"Behav. Pharm."},{"issue":"5","key":"10.1016\/j.neubiorev.2024.105713_bib146","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00213-020-05473-4","article-title":"Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys","volume":"237","author":"Zamarripa","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neubiorev.2024.105713_bib147","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2015.05.053","article-title":"Antagonism of \u03ba opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence","volume":"291","author":"Zan","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.neubiorev.2024.105713_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107536","article-title":"Kappa opioid receptor in nucleus accumbens regulates depressive-like behaviors following prolonged morphine withdrawal in mice","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.neubiorev.2024.105713_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108244","article-title":"Nalfurafine modulates the reinforcing effects of oxycodone in male and female adolescent C57BL\/6J mice","volume":"176","author":"Zhang","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2024.105713_bib150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2015.07.001","article-title":"Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTP\u03b3S binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting","volume":"99","author":"Zhou","year":"2015","journal-title":"Neuropharmacology"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763424001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763424001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:32:02Z","timestamp":1777491122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763424001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":150,"alternative-id":["S0149763424001829"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105713","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the kappa opioid receptor system in opioid use","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105713"}}